)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Avicanna
Avicanna (AVCN) investor relations material
Avicanna Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary14 Aug, 2026
Executive summary
Gross margin improved to 57% in Q2 2026, driven by a 48% quarterly increase in proprietary product sales.
Proprietary QUIXTM rapid-onset portfolio is set for Q3 launch with over 35 commercial listings secured.
Despite an 8% year-over-year revenue decline in Q2, underlying operations showed growth in proprietary product sales and patient/order volumes.
The company navigated significant Veterans Affairs reimbursement changes while maintaining patient and order growth.
Financial highlights
Q2 2026 revenue was $5.64 million, down 8% year-over-year; six-month revenue was $12.32 million, down 1%.
Gross profit reached $3.19 million in Q2, with gross margin rising to 57% from 51% a year earlier.
Adjusted EBITDA loss was $0.36 million in Q2, compared to a $0.25 million loss in Q2 2025.
Working capital deficit reduced to $0.28 million as of June 30, 2026, from $1.28 million at year-end 2025.
Outlook and guidance
Management expects revenue recovery, continued growth initiatives, and further operating efficiencies to support positive adjusted EBITDA in the second half of 2026.
Continued portfolio expansion anticipated in Q3, including the launch of the QUIXTM portfolio.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Avicanna
- Expanded medical portfolio, R&D, and IP drive growth; global scale-up planned for 2026.AVCN
Status Update - Record revenue, improved profitability, and global expansion plans highlighted at the AGM.AVCNAGM 2025
- 340% revenue growth in 2023 and first EBITDA positive quarter highlight strong momentum.AVCNAGM 2024
- Record Q1 2026 revenue and gross profit achieved amid strong Canadian and proprietary product growth.AVCNQ1 2026
- 2025 saw improved margins, reduced losses, and all AGM proposals passed for future growth.AVCNAGM 2026
- Gross margin rose to 53% in 2025, with near break-even EBITDA and global expansion underway.AVCNQ4 2025
- Expanding globally with proprietary cannabinoid medicines and platforms, targeting medical markets.AVCNLife Sciences Virtual Investor Forum
- Revenue and unit sales grew, international reach expanded, and new IP was secured in Q3 2025.AVCNQ3 2025
- Record revenue, margin gains, and global expansion set the stage for 2025 profitability.AVCNQ4 2024
Next Avicanna earnings date
Q3 202612 Nov, 2026
Avicanna
Next Avicanna earnings date
Q3 202612 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage